Estimated ART Delivery Costs under Modeled Scenarios of Efficient ART Scale-Up.

<p>Costs for ART delivery under six modeled scenarios are displayed inclusive of viral load testing. Model costs excluding viral load testing are also shown. <b>Model A:</b> steady-state patient load, MJAP program salary scale and standard core laboratory monitoring schedule. <b>Model B:</b> model A + lowest available ARV drug costs. <b>Model C:</b> model B + Uganda Ministry of Health 2013 salary scales. <b>Model D:</b> model C + increased healthcare worker efficiency due to full use of workday. <b>Model E:</b> model D + expansion of healthcare worker effort to full 8-hour workday. <b>Model F:</b> model E + higher MJAP program salary scales.</p

Sensitivity Analyses of Varying Efficiency/Gain Scenarios.

<p>Sensitivity Analyses of Varying Efficiency/Gain Scenarios.</p

Unit Cost Estimates for Antiretroviral Therapy Delivery (2012 $US).

<p>Unit Cost Estimates for Antiretroviral Therapy Delivery (2012 $US).</p

Inclusivity in global research.

(PDF)</p

Consort diagram.

Consort diagram.</p

Consort checklist.

(DOC)</p

Retention in care at 3 months, stratified by baseline participant characteristics.

Retention in care at 3 months, stratified by baseline participant characteristics.</p

Study protocol.

(DOCX)</p

Hypertension control at 3 months, stratified by baseline participant characteristics.

Hypertension control at 3 months, stratified by baseline participant characteristics.</p

Baseline characteristics.

Baseline characteristics.</p